Swiss National Bank purchased a new position in shares of Viewray Inc (NASDAQ:VRAY) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,900 shares of the company’s stock, valued at approximately $359,000. Swiss National Bank owned about 0.07% of Viewray at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Sei Investments Co. acquired a new stake in Viewray in the 2nd quarter worth about $121,000. Raymond James Financial Services Advisors Inc. acquired a new stake in Viewray in the 2nd quarter worth about $131,000. Barclays PLC boosted its stake in Viewray by 416.1% in the 1st quarter. Barclays PLC now owns 25,041 shares of the company’s stock worth $161,000 after buying an additional 20,189 shares during the last quarter. UBS Group AG boosted its stake in Viewray by 1,100.6% in the 1st quarter. UBS Group AG now owns 35,525 shares of the company’s stock worth $228,000 after buying an additional 32,566 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC boosted its stake in Viewray by 255.9% in the 2nd quarter. Quantitative Systematic Strategies LLC now owns 37,440 shares of the company’s stock worth $259,000 after buying an additional 26,920 shares during the last quarter. Institutional investors and hedge funds own 91.37% of the company’s stock.
NASDAQ VRAY traded up $0.28 during mid-day trading on Friday, reaching $8.74. 1,176,980 shares of the company’s stock traded hands, compared to its average volume of 1,064,828. Viewray Inc has a 1-year low of $5.50 and a 1-year high of $13.21. The company has a quick ratio of 2.64, a current ratio of 3.33 and a debt-to-equity ratio of 1.17. The firm has a market cap of $703.93 million, a PE ratio of -8.40 and a beta of 1.11.
A number of analysts have issued reports on the company. Mizuho reissued a “buy” rating and issued a $13.00 price target on shares of Viewray in a research note on Monday, August 6th. BTIG Research restated a “buy” rating and issued a $14.00 price objective on shares of Viewray in a report on Tuesday, August 7th. BidaskClub downgraded Viewray from a “buy” rating to a “hold” rating in a report on Wednesday, August 8th. ValuEngine upgraded Viewray from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 24th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $13.00 target price on shares of Viewray in a report on Wednesday, October 3rd. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $12.58.
In related news, major shareholder International Ltd Fosun acquired 2,702,702 shares of Viewray stock in a transaction that occurred on Thursday, August 30th. The stock was acquired at an average price of $9.25 per share, for a total transaction of $24,999,993.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Fmr Llc sold 295,850 shares of the business’s stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $12.08, for a total value of $3,573,868.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 3,436,496 shares of company stock valued at $36,326,958. Insiders own 43.93% of the company’s stock.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Recommended Story: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.